Not applicableStudy completedNCT01833325What this trial is testingProton Radiation Therapy for Macular DegenerationWho this might be right forAge-Related Macular Degeneration University of Florida 9
Not applicableStudy completedNCT00539734What this trial is testingChanges in Retinal Function After Intravitreal Ranibizumab for Age-related Macular DegenerationWho this might be right forAge-related Macular Degeneration Prince of Songkla University 25
Large-scale testing (Phase 3)Study completedNCT00000150What this trial is testingSubmacular Surgery Trials (SST)Who this might be right forMacular DegenerationHistoplasmosis National Eye Institute (NEI)
Large-scale testing (Phase 3)Study completedNCT00593450What this trial is testingComparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin TrialWho this might be right forAge Related Macular Degeneration University of Pennsylvania 1,208
Post-approval studies (Phase 4)Study completedNCT03117634What this trial is testingAn Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal VasculopathyWho this might be right forAge Related Macular DegenerationPolypoidal Choroidal Vasculopathy Singapore National Eye Centre 54
Testing effectiveness (Phase 2)UnknownNCT00100087What this trial is testingSafety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy SystemWho this might be right forMacular DegenerationChoroidal Neovascularization Theragenics Corporation 30
Large-scale testing (Phase 3)Looking for participantsNCT07440225What this trial is testingA Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)Who this might be right forMacular DegenerationAge-Related Macular DegenerationChoroidal Neovascularization+1 more EyeBiotech Ltd. 960
Testing effectiveness (Phase 2)Study completedNCT00376701What this trial is testingCombination Therapy for Age-Related Macular Degeneration.Who this might be right forAge Related Macular Degeneration London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 103
Not applicableStudy completedNCT05969418What this trial is testingDeep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVCWho this might be right forMacular Degeneration Choroidal Neovascularization Federico II University 50
Not applicableLooking for participantsNCT07255859What this trial is testingCRYSTALSIGHT Cohort 2.0Who this might be right forMaculopathy Tan Tock Seng Hospital 60
Large-scale testing (Phase 3)Ended earlyNCT00433017What this trial is testingVerteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)Who this might be right forMacular DegenerationChoroidal Neovascularization Novartis 255
Not applicableStudy completedNCT00845273What this trial is testingLong-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular DegenerationWho this might be right forMacular Degeneration Pfizer 3,538
Not applicableUnknownNCT01531842What this trial is testingA Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the EyeWho this might be right forCentral Retinal Vein OcclusionChoroidal NeovascularizationAge-related Macular Degeneration+1 more Mid Atlantic Retina 30
Post-approval studies (Phase 4)Study completedNCT04679935What this trial is testingEfficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular DegenerationWho this might be right forAge-related Macular Degeneration Novartis Pharmaceuticals 52
Not applicableEnded earlyNCT02625376What this trial is testingResveratrol for Exudative Age-Related Macular DegenerationWho this might be right forAMDAge-related Macular DegenerationChoroidal Neovascularisation Poitiers University Hospital 25
Not applicableStudy completedNCT00379795What this trial is testingAn Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVOWho this might be right forChoroidal Neovascularization, Age-related Macular Degeneration Genentech, Inc. 853
Testing effectiveness (Phase 2)Study completedNCT00733304What this trial is testingAn Extension to Study MD7108240Who this might be right forMacular Degeneration GlaxoSmithKline 42
Testing effectiveness (Phase 2)Study completedNCT01157715What this trial is testingA Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMDWho this might be right forNeovascular Age-related Macular Degeneration Chengdu Kanghong Biotech Co., Ltd. 122
Not applicableStudy completedNCT05662943What this trial is testingOutcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCVWho this might be right forPolypoidal Choroidal VasculopathyChoroidal NeovascularizationAge-Related Macular Degeneration Kim's Eye Hospital 135
Large-scale testing (Phase 3)Study completedNCT04264819What this trial is testingStudy of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular DegenerationWho this might be right forNeovascular Age-Related Macular Degeneration Novartis Pharmaceuticals 295